Alzheimer's Disease and Immune Response: A Brief Overview
Received Date: May 30, 2017 / Accepted Date: Aug 31, 2017 / Published Date: Sep 07, 2017
Abstract
Alzheimer disease (AD) is a chronic neurodegenerative disease, which it occurs degeneration of the neurons. The early symptom of AD is short-term memory loss and in chronic, it is characterized by language problems, insidious in onset problems, impairment of activities, mood swings, loss of motivation, hoarding, not managing self-care and behavioral issues. AD is neuropathologically characterized by amyloid beta plaques surrounded by neurons containing neurofibrillary tangles in the brain. The molecules of amyloid beta become toxic to the area, and they are flagged by the body to be cleared. Immune cells as Microglia, Astrocytes and neurons are liable for inflammatory reaction that activate and produce inflammatory mediators to clear cellular debris from the damage area. However, these clearing processes are triggered by the different immunological processes, which can provide through immunotherapeutic approach. The purpose of this review article is to brief cellular neuroimmunological aspects of AD, describes advances in the use of immunotherapy for treatment of AD and highlights ongoing efforts to develop novel therapies.
Keywords: Alzheimer’s disease; Immune cells; Immunotherapy; Inflammation
Citation: Mishra SK, Singh SK (2017) Alzheimer’s Disease and Immune Response: A Brief Overview. J Alzheimers Dis Parkinsonism 7: 371. Doi: 10.4172/2161-0460.1000371
Copyright: © 2017 Mishra SK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any edium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 5472
- [From(publication date): 0-2017 - Sep 01, 2024]
- Breakdown by view type
- HTML page views: 4725
- PDF downloads: 747